---

Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre

---

Original Article

Author Details : Priyanka Patra, Anitha M., HL Vishwanath

Volume : 4, Issue : 1, Year : 2017

Article Page : 99-102

Suggest article by email

Get Permission

---

Abstract

Background: Cardiovascular manifestations are frequent findings in patients with thyroid hormone disorders. Asymmetric dimethylarginine (ADMA), a inhibitor of endothelial nitric oxide synthase (eNOS), blocks nitric oxide (NO) synthesis from l-arginine. So, ADMA level can be considered as cardiovascular risk marker as it is a possible contributing factors for endothelial dysfunction in hyperthyroid patients.
Objectives: The aim of the study was to assess ADMA levels in hyperthyroidism patients free of cardiovascular risk associates and further comparison with healthy controls.
Methodology: The study took place in Victoria Hospital, attached to Bangalore Medical College and Research Institute. The study groups consisted of 30 patients with diagnosed hyperthyroidism and 30 healthy sex and age matched controls. The patients with renal failure, diabetes and severe hypertension were excluded. ADMA was estimated by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA).
Results: The Mean ADMA level was higher in the hyperthyroid group (1.1346±0.6382?mol/L) than in the control group (0.584±0.2377?mol/L) and it was statistically significant (p<0.0001). 
Conclusion: ADMA represents a new and well-characterized marker that has been associated with many traditional and novel risk factors in the setting of cardiovascular risk. So, an elevation of ADMA levels of patients with hyperthyroidism compared with healthy controls may contribute to some cardiovascular alterations.

Keywords: ADMA= Asymmetric dimethylarginine, eNOS = endothelial nitric oxide synthase, NO= nitric oxide, ELISA= enzyme-linked immunosorbent assay, p = Probability of observing a test statistic

How to cite : Patra P, Anitha M., Vishwanath H, Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre. Int J Clin Biochem Res 2017;4(1):99-102

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.